Berwyn-based Drug Platform Company Publishes Results of Alzheimer’s and Parkinson’s Animal Studies
BERWYN, PA — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases, published data from its two double-blind, placebo-controlled …
Read More